National statement of clinical and therapeutic approach of patients with systemic sclerosis-associated interstitial lung disease in Belgium on behalf of the Flemish network on rare connective tissue diseases

OBJECTIVE: Systemic sclerosis (SSc) is a rare autoimmune connective tissue disease characterized by multi-organ involvement and a substantial burden of morbidity and mortality. Following the recent national adoption of the European Reference Network on Rare and Complex Connective Tissue and Musculoskeletal Diseases (ReCONNET) SSc patient pathways by the Flemish Network on Rare Connective Tissue Diseases, this statement aims to provide a comprehensive overview of the clinical and therapeutic management of systemic sclerosis-associated interstitial lung disease (SSc-ILD) within the Belgian healthcare setting. METHODS: A multidisciplinary panel of Belgian experts in interstitial lung disease and systemic sclerosis, together with patient representatives, reviewed current evidence and international recommendations. The panel developed consensus-based guidance adapted to the Belgian context, taking into account clinical practice, healthcare organization and treatment accessibility. RESULTS: The expert panel consolidated key recommendations for the diagnosis, monitoring, multidisciplinary management and treatment of SSc-ILD. Particular emphasis was placed on addressing the complexities of disease management and the high morbidity and mortality associated with SSc-ILD, while ensuring applicability within the Belgian healthcare system. CONCLUSION: Despite the availability of international guidelines for SSc-ILD, differences in therapeutic access, reimbursement policies and the organization of multidisciplinary care necessitate country-specific guidance. This Belgian expert statement aims to support harmonized, equitable and timely access to optimal care for patients with SSc-ILD.

Authors

Institutions

Publication Details

Journal
Acta Clinica Belgica
Published
2026-11-18
DOI
https://doi.org/10.1080/17843286.2026.2759668
Primary Topic
Systemic Sclerosis and Related Diseases
Type
article
Field-Weighted Citation Impact
0.00

Funders

Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
NOV
article

National statement of clinical and therapeutic approach of patients with systemic sclerosis-associated interstitial lung disease in Belgium on behalf of the Flemish network on rare connective tissue diseases

René Westhovens, Charissa Hermine Frank, R. Louis, Marie Vanthuyne et al.
Acta Clinica Belgica
Systemic Sclerosis and Related Diseases
article

National statement of clinical and therapeutic approach of patients with systemic sclerosis-associated interstitial lung disease in Belgium on behalf of the Flemish network on rare connective tissue diseases

René Westhovens, Charissa Hermine Frank, R. Louis, Marie Vanthuyne, Sofia Ajeganova, Caroline Dahlqvist, Margot Van Mechelen, V. Smith, Anne-Noëlle Frix, Julien Guiot, Antoine Froidure, Fanny Gester, Ellen De Langhe, Jan Leo Lenaerts, Geert R. Van Pottelberge, Tessa Du Four, Mirko Petrović, Thomas Renson, Eva Degraeuwe, Anaïs Depicker, Yves Piette, Anneleen Moeyersoons, Daniël Blockmans, Naomi Aerts, I. Hennes, K. Polfliet, Femke Demolder, Clio Ribbens, Béatrice André, Guy G Brusselle, W.A. Wuyts, N. Gusbin, P. De Haes, R. De Bruyne, C. Belge, E. Docampo, D. Ruttens, D. Van Assche, K. Thevissen, K. Melsens, F. Dujardin, G. Wirtz, J. Goubau, M. Leys, B. Bondue, I. Hoffman, E. Vandecasteele, H. Slabbynck, I. Vos, C. De Cock, M. De Decker
article en

Abstract

OBJECTIVE: Systemic sclerosis (SSc) is a rare autoimmune connective tissue disease characterized by multi-organ involvement and a substantial burden of morbidity and mortality. Following the recent national adoption of the European Reference Network on Rare and Complex Connective Tissue and Musculoskeletal Diseases (ReCONNET) SSc patient pathways by the Flemish Network on Rare Connective Tissue Diseases, this statement aims to provide a comprehensive overview of the clinical and therapeutic management of systemic sclerosis-associated interstitial lung disease (SSc-ILD) within the Belgian healthcare setting. METHODS: A multidisciplinary panel of Belgian experts in interstitial lung disease and systemic sclerosis, together with patient representatives, reviewed current evidence and international recommendations. The panel developed consensus-based guidance adapted to the Belgian context, taking into account clinical practice, healthcare organization and treatment accessibility. RESULTS: The expert panel consolidated key recommendations for the diagnosis, monitoring, multidisciplinary management and treatment of SSc-ILD. Particular emphasis was placed on addressing the complexities of disease management and the high morbidity and mortality associated with SSc-ILD, while ensuring applicability within the Belgian healthcare system. CONCLUSION: Despite the availability of international guidelines for SSc-ILD, differences in therapeutic access, reimbursement policies and the organization of multidisciplinary care necessitate country-specific guidance. This Belgian expert statement aims to support harmonized, equitable and timely access to optimal care for patients with SSc-ILD.

Acta Clinica Belgica
Cliniques Universitaires Saint-Luc (BE), Université Libre de Bruxelles (BE), Vrije Universiteit Brussel (BE), University of Liège (BE), Centre Hospitalier de Luxembourg (LU), Universitair Ziekenhuis Leuven (BE), AZ Groeninge (BE), Ghent University Hospital (BE), Erasmus Hospital (BE), Ghent University (BE), CHU Dinant Godinne UCL Namur (BE), Jessa Hospital (BE), Antwerp University Hospital (BE), AZ Sint-Jan (BE), Universitair Ziekenhuis Brussel (BE), Centre Hospitalier Universitaire de Liège (BE), VIB-UGent Center for Inflammation Research (BE), AZ Maria Middelares (BE), Ziekenhuis Oost-Limburg (BE), Centre hospitalier régional de la Citadelle (BE), Ehlers-Danlos Society (US), Ziekenhuis aan de Stroom (BE), Hasselt University (BE), UCLouvain (BE), KU Leuven (BE)
Fonds Wetenschappelijk Onderzoek, Vlaamse regering
Good health and well-being
Systemic Sclerosis and Related Diseases
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Laika access coming soon